Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News May 20 2025 | Acoramidis Reduced Incidence of Atrial Fibrillation Events in Patients with ATTR-CM Industry News In The News Industry Read More May 19 2025 | Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study Industry News In The News Industry Read More May 14 2025 | Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal Industry News In The News Industry Read More May 13 2025 | First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study Industry News In The News Industry Read More May 12 2025 | BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
May 20 2025 | Acoramidis Reduced Incidence of Atrial Fibrillation Events in Patients with ATTR-CM Industry News In The News Industry Read More
May 19 2025 | Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study Industry News In The News Industry Read More
May 14 2025 | Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal Industry News In The News Industry Read More
May 13 2025 | First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study Industry News In The News Industry Read More
May 12 2025 | BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC Industry News In The News Industry Read More
